CFN Enterprises Inc. Adds CB Therapeutics to Rapidly Growing Psychedelic Client Roster

Posted by Newsfile October 6, 2020

CB Therapeutics is building a synthetic biology platform to solve mankind’s most challenging mental healthcare and social challenges.

Whitefish, Montana–(Newsfile Corp. – October 6, 2020) – CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network and agency dedicated to the global legal cannabis, CBD and psychedelics industries, today announced the addition of CB Therapeutics Inc. to its growing client roster in the psychedelics industry.

Powered by WPeMatico

Tags:
Newsfile
View More Posts
Newsfile is a customer-focused newswire team that delivers press releases and corporate announcements to the global financial community. Approved by all stock exchanges, Newsfile offers broad access to media, analysts, investors and market participants. With agile services, proactive customer care and affordable pricing; Newsfile makes it easy for companies to tell their story to the audiences they need to reach.